Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy

被引:46
作者
Natsumeda, Manabu [1 ]
Igarashi, Hironaka [2 ]
Nomura, Toshiharu [1 ]
Ogura, Ryosuke [1 ]
Tsukamoto, Yoshihiro [1 ]
Kobayashi, Tsutomu [1 ]
Aoki, Hiroshi [1 ]
Okamoto, Kouichirou [1 ]
Kakita, Akiyoshi [3 ]
Takahashi, Hitoshi [3 ]
Nakada, Tsutomu [2 ]
Fujii, Yukihiko [1 ]
机构
[1] Niigata Univ, Brain Res Inst, Dept Neurosurgery, Niigata, Japan
[2] Niigata Univ, Brain Res Inst, Ctr Integrated Brain Sci, Niigata, Japan
[3] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan
关键词
Glioma; MRS; 2-hydroxyglutarate; IDH mutation; Prognostic marker; IN-VIVO; ONCOMETABOLITE; 2-HYDROXYGLUTARATE; IDH1; MUTATIONS; MUTANT IDH1; GROWTH; EXPRESSION; INHIBITOR; CELLS;
D O I
10.1186/s40478-014-0158-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Previous magnetic resonance spectroscopy (MRS) and mass spectroscopy studies have shown accumulation of 2-hydroxyglutarate (2HG) in mutant isocitrate dehydrogenase (IDH) gliomas. IDH mutation is known to be a powerful positive prognostic marker in malignant gliomas. Hence, 2HG accumulation in gliomas was assumed to be a positive prognostic factor in gliomas, but this has not yet been proven. Here, we analyzed 52 patients harboring World Health Organization (WHO) grade II and III gliomas utilizing 3.0-tesla MRS. Results: Mutant IDH gliomas showed significantly higher accumulation of 2HG (median 5.077 vs. 0.000, p = 0.0002, Mann-Whitney test). 2HG was detectable in all mutant IDH gliomas, whereas in 10 out of 27 (37.0%) wild-type IDH gliomas, 2HG was below the detectable range (2HG = 0) (p = 0.0003, chi-squared test). Screening for IDH mutation by 2HG analysis was highly sensitive (cutoff 2HG = 1.489 mM, sensitivity 100.0%, specificity 72.2%). Gliomas with high 2HG accumulation had better overall survival than gliomas with low 2HG accumulation (p = 0.0401, Kaplan-Meier analysis). Discussion: 2HG accumulation detected by 3.0-tesla MRS not only correlates well with IDH status, but also positively correlates with survival in WHO grade II and III gliomas.
引用
收藏
页数:7
相关论文
共 43 条
[1]   Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate [J].
Andronesi, Ovidiu C. ;
Rapalino, Otto ;
Gerstner, Elizabeth ;
Chi, Andrew ;
Batchelor, Tracy T. ;
Cahil, Dan P. ;
Sorensen, A. Gregory ;
Rosen, Bruce R. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (09) :3659-3663
[2]   Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy [J].
Andronesi, Ovidiu C. ;
Kim, Grace S. ;
Gerstner, Elizabeth ;
Batchelor, Tracy ;
Tzika, Aria A. ;
Fantin, Valeria R. ;
Vander Heiden, Matthew G. ;
Sorensen, A. Gregory .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (116)
[3]   Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia [J].
Ashraf, Saquib ;
Noguera, Nelida I. ;
Di Giandomenico, Jonny ;
Zaza, Serena ;
Hasan, Syed Khizer ;
Lo-Coco, Francesco .
ANNALS OF HEMATOLOGY, 2013, 92 (10) :1319-1323
[4]   IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection [J].
Beiko, Jason ;
Suki, Dima ;
Hess, Kenneth R. ;
Fox, Benjamin D. ;
Cheung, Vincent ;
Cabral, Matthew ;
Shonka, Nicole ;
Gilbert, Mark R. ;
Sawaya, Raymond ;
Prabhu, Sujit S. ;
Weinberg, Jeffrey ;
Lang, Frederick F. ;
Aldape, Kenneth D. ;
Sulman, Erik P. ;
Rao, Ganesh ;
McCutcheon, Ian E. ;
Cahill, Daniel P. .
NEURO-ONCOLOGY, 2014, 16 (01) :81-91
[5]   Monoclonal antibody specific for IDH1 R132H mutation [J].
Capper, David ;
Zentgraf, Hanswalter ;
Balss, Joerg ;
Hartmann, Christian ;
von Deimling, Andreas .
ACTA NEUROPATHOLOGICA, 2009, 118 (05) :599-601
[6]   Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068
[7]   A comparative study of short- and long-TE 1H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors [J].
Choi, Changho ;
Ganji, Sandeep ;
Hulsey, Keith ;
Madan, Akshay ;
Kovacs, Zoltan ;
Dimitrov, Ivan ;
Zhang, Song ;
Pichumani, Kumar ;
Mendelsohn, Dianne ;
Mickey, Bruce ;
Malloy, Craig ;
Bachoo, Robert ;
DeBerardinis, Ralph ;
Maher, Elizabeth .
NMR IN BIOMEDICINE, 2013, 26 (10) :1242-1250
[8]   2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas [J].
Choi, Changho ;
Ganji, Sandeep K. ;
DeBerardinis, Ralph J. ;
Hatanpaa, Kimmo J. ;
Rakheja, Dinesh ;
Kovacs, Zoltan ;
Yang, Xiao-Li ;
Mashimo, Tomoyuki ;
Raisanen, Jack M. ;
Marin-Valencia, Isaac ;
Pascual, Juan M. ;
Madden, Christopher J. ;
Mickey, Bruce E. ;
Malloy, Craig R. ;
Bachoo, Robert M. ;
Maher, Elizabeth A. .
NATURE MEDICINE, 2012, 18 (04) :624-629
[9]   The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases [J].
Chowdhury, Rasheduzzaman ;
Yeoh, Kar Kheng ;
Tian, Ya-Min ;
Hillringhaus, Lars ;
Bagg, Eleanor A. ;
Rose, Nathan R. ;
Leung, Ivanhoe K. H. ;
Li, Xuan S. ;
Woon, Esther C. Y. ;
Yang, Ming ;
McDonough, Michael A. ;
King, Oliver N. ;
Clifton, Ian J. ;
Klose, Robert J. ;
Claridge, Timothy D. W. ;
Ratcliffe, Peter J. ;
Schofield, Christopher J. ;
Kawamura, Akane .
EMBO REPORTS, 2011, 12 (05) :463-469
[10]   Diffuse glioma growth: a guerilla war [J].
Claes, An ;
Idema, Albert J. ;
Wesseling, Pieter .
ACTA NEUROPATHOLOGICA, 2007, 114 (05) :443-458